These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16043165

  • 1. The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS.
    Fuchs B, Schiller J, Wagner U, Häntzschel H, Arnold K.
    Clin Biochem; 2005 Oct; 38(10):925-33. PubMed ID: 16043165
    [Abstract] [Full Text] [Related]

  • 2. Phospholipid compositions of sera and synovial fluids from dog, human and horse: a comparison by 31P-NMR and MALDI-TOF MS.
    Fuchs B, Bondzio A, Wagner U, Schiller J.
    J Anim Physiol Anim Nutr (Berl); 2009 Aug; 93(4):410-22. PubMed ID: 18484967
    [Abstract] [Full Text] [Related]

  • 3. Parameters affecting the accuracy of the MALDI-TOF MS determination of the phosphatidylcholine/lysophosphatidylcholine (PC/LPC) ratio as potential marker of spermatozoa quality.
    Bresler K, Pyttel S, Paasch U, Schiller J.
    Chem Phys Lipids; 2011 Oct; 164(7):696-702. PubMed ID: 21827741
    [Abstract] [Full Text] [Related]

  • 4. A fast method for the determination of the PC/LPC ratio in intact serum by MALDI-TOF MS: an easy-to-follow lipid biomarker of inflammation.
    Angelini R, Vortmeier G, Corcelli A, Fuchs B.
    Chem Phys Lipids; 2014 Oct; 183():169-75. PubMed ID: 25016154
    [Abstract] [Full Text] [Related]

  • 5. Determination of the Phosphatidylcholine/Lysophosphatidylcholine Ratio in Intact Serum by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry with Prior Enzymatic Albumin Digestion.
    Ditz T, Fuchs B.
    Lipids; 2018 Oct; 53(10):971-977. PubMed ID: 30485452
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of carbon tetrachloride-induced stress on rat hepatocytes by 31P NMR and MALDI-TOF mass spectrometry: lysophosphatidylcholine generation from unsaturated phosphatidylcholines.
    Bauer A, Schumann A, Gilbert M, Wilhelm C, Hengstler JG, Schiller J, Fuchs B.
    Chem Phys Lipids; 2009 May; 159(1):21-9. PubMed ID: 19428359
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease.
    Miletić Vukajlović J, Drakulić D, Pejić S, Ilić TV, Stefanović A, Petković M, Schiller J.
    Rapid Commun Mass Spectrom; 2020 Feb 28; 34(4):e8595. PubMed ID: 31519070
    [Abstract] [Full Text] [Related]

  • 8. Enhanced lysophosphatidylcholine and sphingomyelin contents are characteristic of spermatozoa from obese men-A MALDI mass spectrometric study.
    Pyttel S, Zschörnig K, Nimptsch A, Paasch U, Schiller J.
    Chem Phys Lipids; 2012 Dec 28; 165(8):861-5. PubMed ID: 23146833
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis-associated changes in the glycerophospholipid composition of hematopoietic progenitor cells monitored by 31P NMR spectroscopy and MALDI-TOF mass spectrometry.
    Fuchs B, Schiller J, Cross MA.
    Chem Phys Lipids; 2007 Dec 28; 150(2):229-38. PubMed ID: 17919519
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis.
    Sinz A, Bantscheff M, Mikkat S, Ringel B, Drynda S, Kekow J, Thiesen HJ, Glocker MO.
    Electrophoresis; 2002 Sep 28; 23(19):3445-56. PubMed ID: 12373775
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D, Fillet M, Meuwis MA, Geurts P, Lutteri L, Ribbens C, Bours V, Wehenkel L, Piette J, Malaise M, Merville MP.
    Arthritis Rheum; 2005 Dec 28; 52(12):3801-12. PubMed ID: 16320331
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
    Popa C, Netea MG, Radstake T, Van der Meer JW, Stalenhoef AF, van Riel PL, Barerra P.
    Ann Rheum Dis; 2005 Feb 28; 64(2):303-5. PubMed ID: 15231512
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.